Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Comment by narmacon Oct 02, 2022 10:49am
141 Views
Post# 35000142

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Prothena and Management's Reporting

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Prothena and Management's ReportingMy 2 cents,,,any PhDs I had an oprtunity to work with over the past years were sincere and interesting people,,,and I grew up beside one,,we have a load of these highly educated people involved and who are hands on with this company. I dont think they intend to embarrass themselves by pushing snake oil technology. Nor do I believe they intentionally mislead us in what the future could hold.

When The Team here say GBS Pll initiated by year end,,,,,and or,,a nasdaq listing is coming within months and also shooting for two Pll trials in 2023, I think they are sincere.

How it transpires is the gamble! But as a run of the mill investor I am taking that chance we actually do make inroads with our science! These next 15 months will hopefully give us an idea of what capabilites our team has and what xB3 can really do against disease.

Bring it on team,,,,,,,and of course we will see BTI to daaaaaaaa moooooooooooooooon!!!!!!!!!,,JMO.
<< Previous
Bullboard Posts
Next >>